Naga Rajiv Lakkaniga

AI-enabled remote monitoring of vital signs for COVID-19: methods, prospects and challenges

Honnesh Rohmetra, Navaneeth Raghunath, Pratik Narang et al. · Computing · 2021 · 93 citations · Full text

Computing, Health Informatics, Infectious Diseases +14

Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application

Wei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno et al. · Journal of Medicinal Chemistry · 2018 · 87 citations · Full text

Medicine, Molecular Biology, Oncology +17

Discovery of SP-96, the first non-ATP-competitive Aurora Kinase B inhibitor, for reduced myelosuppression

Naga Rajiv Lakkaniga, Lingtian Zhang, Binyam Belachew et al. · European Journal of Medicinal Chemistry · 2020 · 41 citations · Full text

Medicine, Oncology, Pharmacology +5

Catalyst free, C-3 functionalization of imidazo[1,2-<i>a</i>]pyridines to rapidly access new chemical space for drug discovery efforts

Gunaganti Naresh, Anupreet Kharbanda, Naga Rajiv Lakkaniga et al. · Chemical Communications · 2018 · 37 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +14

Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of RET: Design, synthesis and biological evaluation

Naga Rajiv Lakkaniga, Gunaganti Naresh, Lingtian Zhang et al. · European Journal of Medicinal Chemistry · 2020 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9